SV Health Investors

← Back to your selection

All recorded activity

Rounds participated in: 4
Confirmed lead rounds: —
New companies: 4
Funding in participating rounds: $463M

By stage

Undisclosed2

Series B1

Series C+1

By primary sector

Biotech3

Healthtech1

By country

United States2

Australia1

United Kingdom1

Rounds

4 in all activity

Jul 15

AdvanCell

Develops lead-212 targeted alpha therapies to treat cancer

$315MSeries D

Role not disclosed

Jul 14

Draig Therapeutics

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries B

Role not disclosed

Jan 27

TRex Bio

Develops precision immunoregulatory medicines based on tissue Treg biology

$50MUndisclosed

Role not disclosed

Jan 13

PayMedix

Provides healthcare financing and payments solutions

$33MUndisclosed

Role not disclosed

← Back to your selection

All recorded activity

Rounds participated in: 4
Confirmed lead rounds: —
New companies: 4
Funding in participating rounds: $463M

By stage

Undisclosed2

Series B1

Series C+1

By primary sector

Biotech3

Healthtech1

By country

United States2

Australia1

United Kingdom1

Rounds

4 in all activity

Jul 15

AdvanCell

Develops lead-212 targeted alpha therapies to treat cancer

$315MSeries D

Role not disclosed

Jul 14

Draig Therapeutics

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries B

Role not disclosed

Jan 27

TRex Bio

Develops precision immunoregulatory medicines based on tissue Treg biology

$50MUndisclosed

Role not disclosed

Jan 13

PayMedix

Provides healthcare financing and payments solutions

$33MUndisclosed

Role not disclosed